Insights from leading international and Australian experts in ophthalmology.



Brolucizumab Update-Presented by Dr Sophia Zagora

Please join Retinal and Uveitis specialist Dr Sophia Zagora as she takes the viewer through the journey of brolucizumab to date including an update on post marketing surveillance of Brolucizumab since the USA launch in October 2019.


Vision: Real world perspectives

International ophthalmology expert Prof. Frank Holz discusses safety insights, real world experience with Beovu and treatment for wet AMD.




Beovu Treatment Journey

Overall, how does Beovu® (brolucizumab) change the treatment journey for wet AMD paitents and their caregivers?


Switching Considerations

When do you consider switching your patients to Beovu® (brolucizumab)?




Beovu and other aVEGFs

What differentiates Beovu® (brolucizumab) from existing anti-VEGFs?


Consenting Patients

What key points do you disucss with your patients when counselling them on starting treatment with Beovu® (brolucizumab)?




Medical Information Request